Seeking Alpha

Idenix +7% as Klarman boosts stake and involvement

  • Baupost's latest 13D shows a 39.8%, or 53.3M share stake in Indenix Pharmaceuticals (IDIX) vs 35% at last report. Baupost also say's it's engaged management and has been granted observer rights to board meetings.
  • Shares +7.3% AH
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: